|Day 2||Day 3||Day 4||Day 5|| |
Day 6 and
|AM||AM||PM||AM||PM||AM||PM||AM||PM||AM||PM||10 mg||10 mg||10 mg||10 mg||20 mg||20 mg||20 mg||20 mg||30 mg||30 mg||30 mg|
|Day 1||10 mg||–|
|Day 2||10 mg||10 mg|
|Day 3||10 mg||20 mg|
|Day 4||20 mg||20 mg|
|Day 5||20 mg||30 mg|
|Day 6 and |
|30 mg||30 mg|
Creatinine clearance (CrCl) <30 mL/min estimated by the Cockcroft–Gault equation.
Ensure your patient has received a sample Starter Pack prior to enrolling. To receive a free bridge supply of Otezla, patients must have an on-label diagnosis. Patients in Massachusetts are not eligible to receive bridge.
Patients that do not receive a sample Starter Pack will only receive Otezla after insurance approval.
Reference: 1. Otezla [package insert]. Summit, NJ: Celgene Corporation.
Indications & Important Safety Information
Please click here for Full Prescribing Information.
Do you wish to leave this site?
8 out of 10
commercially insured lives in the US have preferred access with no biologic step required for Otezla® (apremilast)1